Steroids therapy
Phase 3Small molecule
Steroids therapy is one of 5 small molecule programs targeting Vestibular schwannoma. It is currently in Phase 3.
1
Indications
1
Total Trials
1
Active Trials
4
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
5 competitors in Vestibular Schwannoma
#DrugCompanyPhaseTrials
1Garamycin
SSchering-Plough
Approved
Kenalog
BBausch Health Americas, Inc.
Approved
Nimotop
AAzurity Pharmaceuticals
Approved
Bayer Aspirin
BayerPhase 2
Steroids therapy
BBeijing Tiantan Hospital
Phase 3
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Vestibular schwannoma1 trial
Steroids for Facial Nerve Function Protection in Post-surgical Vestibular Schwannoma Patients
Not yet recruiting·—·Phase 3·NCT07116811·364 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Steroids therapy. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 3[1]
- Company
- BBeijing Tiantan Hospital